HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Péter Arányi Selected Research

Emphysema

4/2003A novel orally active inhibitor of HLE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Péter Arányi Research Topics

Disease

1Coma (Comas)
01/2022
1Ventricular Tachycardia
01/2022
1Ventricular Fibrillation
01/2022
1Myocardial Infarction
03/2017
1Gastroenteritis
03/2017
1Unconsciousness (Loss of Consciousness)
03/2017
1Hypertension (High Blood Pressure)
03/2017
1Ischemia
12/2010
1Reperfusion Injury
08/2009
1Wounds and Injuries (Trauma)
08/2009
1Cystic Fibrosis (Mucoviscidosis)
04/2003
1Chronic Obstructive Pulmonary Disease (COPD)
04/2003
1Asthma (Bronchial Asthma)
04/2003
1Emphysema
04/2003

Drug/Important Bio-Agent (IBA)

1Creatine Kinase (Creatine Phosphokinase)IBA
03/2017
1Troponin IIBA
03/2017
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
03/2017
1Antihypertensive Agents (Antihypertensives)IBA
03/2017
1ThiazidesIBA
03/2017
1SSR 69071IBA
04/2003

Therapy/Procedure

1Resuscitation
01/2022
1Induced Hypothermia
01/2022
1Surgical Amputation (Amputations)
12/2010
1Vascular Surgical Procedures
08/2009